Low-density lipoprotein and its effect on human blood platelets

Cellular and Molecular Life Sciences : CMLS
Ingrid A M RelouE Malle


Events leading to hyperactivity of human blood platelets are accompanied by an enhanced risk of atherosclerosis and arterial thrombosis. Lipoprotein disorders affect platelet functions, and hypersensitive platelets are observed in various stages of hyperlipidemia. Low-density lipoprotein (LDL), a circulating complex of lipids and proteins that is increased in hypercholesterolemia, enhances platelet function and increases sensitivity of platelets to several naturally occurring agonists. LDL sensitizes platelets via binding of apoB-100 to a receptor on the platelet membrane and via transfer of lipids to the platelet membrane. The receptor that mediates binding of LDL to the platelet and initiates subsequent intracellular signaling cascades has not yet been identified. Modification of native LDL generates a platelet-activating particle, and this interaction might contribute to the development of the atherosclerotic plaque. Lysophosphatidic acid is formed upon mild oxidation of LDL and is responsible for subsequent platelet activation induced by the modified LDL particle. Thus, LDL changes the functions of platelets via a broad spectrum of interactions.


Jan 26, 2008·Cardiovascular Research·Dorothea Siegel-AxelMeinrad Gawaz
Aug 26, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hadim AkogluAli Riza Odabas
Nov 17, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Azize SenerMuzaffer Demir
Feb 18, 2010·Transfusion·Katharina RuebsaamenGerd Schmitz
Jan 25, 2008·Clinical and Experimental Pharmacology & Physiology·Rukhsana AslamJohn D Connor
Mar 9, 2005·Annals of the New York Academy of Sciences·John K LodgeAnna R Proteggente
Dec 13, 2005·International Journal of Cardiology·Nina JohnstonLars Wallentin
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Suzanne J A Korporaal, Jan-Willem N Akkerman
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Suzanne J A Korporaal, Jan-Willem N Akkerman
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Elisabeth KollerFranz Koller
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Patrizia FerroniGiovanni Davì
Feb 14, 2017·Thrombosis Journal·Efthymios ArvanitidisElena A Nicu
Apr 21, 2010·Vascular and Endovascular Surgery·Benjamin SadowitzVivian Gahtan
Dec 25, 2007·Annals of Surgery·Trevor M Williams, Alden H Harken
Dec 20, 2007·Journal of Thrombosis and Haemostasis : JTH·Meinrad GawazHarald Langer
Nov 1, 2011·Seminars in Immunopathology·Dimitrios Davalos, Katerina Akassoglou
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Karin DaubMeinrad Gawaz
Oct 29, 2015·Clinical Drug Investigation·Tian-Lin WangRui Wang
Dec 4, 2003·Coronary Artery Disease·Demosthenes B PanagiotakosChristodoulos Stefanadis
Jan 23, 2020·International Journal of Molecular Sciences·Cristina Barale, Isabella Russo
Nov 8, 2018·BioMed Research International·Cristina BaraleIsabella Russo
Dec 30, 2020·International Journal of Molecular Sciences·Lei Wang, Chaojun Tang
Jun 3, 2021·International Journal of Molecular Sciences·Cristina BaraleIsabella Russo

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Cardiovascular & Hematological Agents in Medicinal Chemistry
Suzanne J A Korporaal, J W Akkerman
Arteriosclerosis, Thrombosis, and Vascular Biology
Suzanne J A KorporaalJan-Willem N Akkerman
© 2021 Meta ULC. All rights reserved